Wednesday, September 28, 2022

Latest:

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
Amgen announces Artificial Intelligence (AI) Partnership with Mila

Biotech Stock Market Report

Know First, Act First

Covid-19
General
Financing
Pharma
Global
Trending

Global

BIOTCHNO Global

Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapant

March 1, 2021May 17, 2021 Raza

Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous

BIOTCHNO Global

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa

February 11, 2021April 8, 2021 Bachittar

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa FOSTER CITY, Calif. and

BIOTCHNO Global

Olympus launches comprehensive global educational platform for healthcare professionals

January 31, 2021April 8, 2021 vanessa

Olympus launches comprehensive global educational platform for healthcare professionals Tokyo / Hamburg, Feb 1, 2021 – (ACN Newswire) – Olympus

BIOTCHNO Covid-19

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate

December 14, 2020April 16, 2021 vanessa

VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody

BIOTCHNO Covid-19

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa

BIOTCHNO Covid-19

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa

Disclaimer
Privacy Policy

TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057